Felicia Vonella | Executive Director, IR |
Ron Cohen | CEO |
Lauren Sabella | CCO |
David Lawrence | CTO, Chief of Business Operations & Principal Accounting Officer |
Paul Matteis | Stifel |
Salveen Richter | Goldman Sachs |
Phil Nadeau | Cowen and Company |
Michael Yee | Jefferies |
Charles Duncan | Cantor Fitzgerald |
Edward Marks | HC Wainwright |
Welcome to the Acorda Therapeutics' Second Quarter 2019 Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company’s request.
I will now introduce your host for today's call, Felicia Vonella, Vice President of Investor Relations at Acorda.